{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459444292
| IUPAC_name               = methyl 1-(1-phenylethyl)-1''H''-imidazole-5-carboxylate
| image                    = Metomidate.svg
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number               = 5377-20-8
| ATCvet                   = yes
| ATC_prefix               = N05
| ATC_suffix               = CM94
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Z18ZYL8Y51
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 494039
| PubChem                  = 21474
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID             = 20182
| C = 13 | H = 14 | N = 2 | O = 2
| molecular_weight         = 230.263 g/mol
| smiles                   = O=C(OC)c1cncn1C(c2ccccc2)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI                 = 1S/C13H14N2O2/c1-10(11-6-4-3-5-7-11)15-9-14-8-12(15)13(16)17-2/h3-10H,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey              = FHFZEKYDSVTYLL-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = Rx-only
| routes_of_administration = 
}}

'''Metomidate''' is a non-barbiturate [[imidazole]] that was discovered by [[Janssen Pharmaceutica]] in 1965<ref>BE Patent 662474</ref> and under the names ('''Hypnodil''', '''Nokemyl''') is sold as a [[sedative]]-[[hypnotic]] [[drug]] used in [[Europe]] to treat humans and for veterinary purposes.<ref name="Index nominum 2000: international drug directory">{{cite book | title = Index nominum 2000: international drug directory | url = https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA683 | accessdate = 27 October 2011 | year = 2000 | publisher = Taylor & Francis US | isbn = 978-3-88763-075-1 | pages = 683}}</ref>

[[Isotopes of carbon#Carbon-11|<sup>11</sup>C]]-labelled [[Positron emission tomography#metomidate|metomidate]] (11C-metomidate), may be used with [[positron emission tomography]] (PET). For instance, to detect tumors of [[adrenocortical]] origin.<ref>{{cite journal | display-authors = 4 | author = Khan TS | author2 = Sundin A | author3 = Juhlin C | author4 = Långström B | author5 = Bergström M | author6 = Eriksson B | title = 11C-metomidate PET imaging of adrenocortical cancer | journal = European Journal of Nuclear Medicine and Molecular Imaging | volume = 30 | issue = 3 | pages = 403–410 | date = 2003 | pmid = 12634969 | doi = 10.1007/s00259-002-1025-9 }}</ref><ref>{{cite journal | display-authors = 4 | author = Minn H | author2 = Salonen A | author3 = Friberg J | author4 = Roivainen A | author5 = Viljanen T | author6 = Långsjö J | author7 = Salmi J | author8 = Välimäki M | author9 = Någren K | author10 = Nuutila P | title = Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG | journal = J. Nucl. Med. | volume = 45 | issue = 6 | pages = 972–9 | date = June 2004 | pmid = 15181132 | doi =  | url = http://jnm.snmjournals.org/cgi/content/full/45/6/972 }}</ref>

==See also==
* [[Etomidate]]
* [[Propoxate]]

==References==
{{Reflist|2}}

{{Hypnotics}}
{{General anesthetics}}
{{GABAAR PAMs}}

[[Category:11β-Hydroxylase inhibitors]]
[[Category:Sedatives]]
[[Category:Hypnotics]]
[[Category:General anesthetics]]
[[Category:Ethyl esters]]
[[Category:Imidazoles]]
[[Category:GABAA receptor positive allosteric modulators]]


{{sedative-stub}}